DE:R9Q Stock Latest News
Company AnnouncementsRecce Pharmaceuticals Issues New Shares in Compliant Capital Move3d ago
Company AnnouncementsRecce Pharmaceuticals Seeks ASX Quotation for New Employee Incentive Shares3d ago
Company AnnouncementsRecce strengthens Phase 3 DFI program and expands anti-infective IP in Vietnam4d ago
Company AnnouncementsRecce and Arrotex Strike Exclusive Deal for Diabetic Foot Infection Gel1w ago
Company AnnouncementsRecce Faces Key DMC Review as Phase 3 Diabetic Foot Gel Trial Shows Strong Signals2w ago
Company AnnouncementsRecce Pharmaceuticals Sets 2026 AGM as Synthetic Anti-Infective Pipeline Gains Recognition3w agoCompany AnnouncementsRecce Pharmaceuticals faces shareholder push for governance changes and board shake-up1M ago
Company AnnouncementsRecce Sets 2026 AGM Date as It Advances Synthetic Anti-Infective Pipeline1M ago
Company AnnouncementsRecce Investors Reject Option Issues and Placement Ratification at General Meeting2M ago
Company AnnouncementsRecce Pharmaceuticals Issues Investor Presentation with Extensive Legal Disclaimers2M ago- Company AnnouncementsRecce Pharmaceuticals Files ASX Corporate Governance Statement and Appendix 4G2M ago
Company AnnouncementsRecce Pharmaceuticals Narrows Loss as Global Anti-Infective Programs Advance2M agoCompany AnnouncementsRecce wins Australian approval to expand pivotal Phase 3 diabetic foot trial2M ago
Company AnnouncementsRecce Pharmaceuticals Issues 250,000 New Shares Under Corporations Act Exemption3M ago
Company AnnouncementsRecce Pharmaceuticals Seeks ASX Quotation for Advisory Fee Shares3M ago- Company AnnouncementsRecce Raises A$6.4m via Placement and Share Purchase Plan, Adds Layered Option Incentives3M ago
Company AnnouncementsRecce Pharmaceuticals Seeks ASX Quotation for Over 6 Million New Shares3M ago
Company AnnouncementsRecce Pharmaceuticals Calls September Virtual General Meeting for Shareholders3M agoCompany AnnouncementsRecce Positioned as U.S. Unveils US$66.9 Billion Antimicrobial Biodefense Plan3M ago
